Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05673681Recruiting

Spanish Academy of Dermatology and Venereology (AEDV) Melanoma Registry

Role: lead

NCT05674695Recruiting

Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis Therapy

Role: lead

NCT02075697Unknown

Spanish Registry of Systemic Treatments in Psoriasis

Role: lead

NCT03646422Unknown

AEDV Registry of Primary Cutaneous Lymphoma

Role: lead

NCT02310503Completed

Spanish Registry of Mohs Surgery

Role: lead

All 5 trials loaded